The classic Chimeric Antigen Receptor Macrophage(CAR-M)exerts pro-inflammatory effects to achieve anti-tumor immunity,but by modifying the structure design of CAR,it can acquire anti-inflammatory functions similar to M2,thereby treating inflammatory diseases.Currently,CAR-M therapy targeting M1-type microglial cells can effectively reduce neuroinflammation and be used to treat inflammation-related depression.With ongoing research on the anti-inflammatory effects of CAR-M,CAR-M cell therapy offers a new approach for treating inflammatory-related diseases.
维普
万方数据